ACTG Presents Important Findings from REPRIEVE at CROI 2025
To learn more, please visit www.reprievetrial.org.
ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented data demonstrating that switching to an integrase inhibitor-based antiretroviral regimen increased ...
Hosted on MSN11mon
Editorial: Necessary study of violent extremism gets reprieve
First proposed in 2023 by state Attorney General Bob Ferguson following a six-month study by his office that the Legislature had requested, House Bill 1333 would have created a state Commission on ...
Morningstar3d
ACTG Presents Important Findings from REPRIEVE at CROI 2025
Eron, M.D., University of North Carolina. “REPRIEVE was a groundbreaking study that has informed a multitude of international guidelines, which now recommend statins to prevent cardiovascular ...
Toronto Star3d
ACTG Presents Important Findings from REPRIEVE at CROI 2025
LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) — ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented findings from the REPRIEVE trial about the use ...